Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 154 | $1,077,309,139 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 1,565 | 229.2459 | 358,770 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 1,747 | 230.0496 | 401,897 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 229 | 231.0452 | 52,909 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 38 | 233 | 8,854 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 428 | 234.2728 | 100,269 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 1,272 | 235.4128 | 299,445 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 896 | 236.3695 | 211,787 | D |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 2,535 | 229.2462 | 581,139 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 2,827 | 230.0495 | 650,350 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 371 | 231.0449 | 85,718 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 62 | 233 | 14,446 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 694 | 234.2727 | 162,585 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 2,059 | 235.4128 | 484,715 | I |
10 Oct 2024 17:48 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 08 Oct 2024 | Sale | 1,452 | 236.3695 | 343,209 | I |
02 Oct 2024 19:13 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 30 Sep 2024 | Sale | 1,202 | 237.1 | 284,994 | D |
01 Oct 2024 18:29 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 27 Sep 2024 | Sale | 5,000 | 220.3548 | 1,101,774 | I |
19 Sep 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 19 Sep 2024 | Sale | 4,500 | 200.1366 | 900,615 | D |
19 Sep 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 17 Sep 2024 | Sale | 500 | 200 | 100,000 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 274 | 192.0435 | 52,620 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 700 | 191.2049 | 133,843 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 2,275 | 190.2895 | 432,909 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 2,032 | 188.158 | 382,337 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 275 | 188.9736 | 51,968 | D |
05 Sep 2024 17:40 | BGNE | BeiGene Ltd. | BALL TITUS B. | Principal Accounting Officer | 03 Sep 2024 | Sale | 137 | 189.9413 | 26,022 | D |
01 Aug 2024 17:06 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 30 Jul 2024 | Sale | 834 | 160.57 | 133,915 | D |
03 Jul 2024 17:05 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 01 Jul 2024 | Sale | 472 | 143.8955 | 67,919 | D |
26 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 24 Jun 2024 | Sale | 899 | 155.66 | 139,938 | D |
26 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 24 Jun 2024 | Sale | 2 | 161.1 | 322 | D |
26 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 24 Jun 2024 | Sale | 1,062 | 159.8 | 169,708 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 23 | 161.27 | 3,709 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 400 | 160.3782 | 64,151 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 1,036 | 159.5297 | 165,273 | D |
26 Jun 2024 17:22 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 24 Jun 2024 | Sale | 400 | 160.1237 | 64,049 | D |
26 Jun 2024 17:22 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 24 Jun 2024 | Sale | 2,389 | 159.4894 | 381,020 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 608 | 159.3984 | 96,914 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 376 | 159.9113 | 60,127 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 297 | 158.5309 | 47,084 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 314 | 159.7408 | 50,159 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 253 | 158.9981 | 40,227 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 195 | 158.5843 | 30,924 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 154 | 158.2368 | 24,368 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 18 Jun 2024 | Sale | 841 | 153.7512 | 129,305 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 300 | 159.9019 | 47,971 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 485 | 159.4241 | 77,321 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 478 | 158.9981 | 76,001 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 237 | 158.5002 | 37,565 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 300 | 156.8033 | 47,041 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 300 | 155.1492 | 46,545 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 906 | 154.1722 | 139,680 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 1,121 | 153.6575 | 172,250 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 17 Jun 2024 | Sale | 627 | 158.9981 | 99,692 | D |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 129 | 159.7353 | 20,606 | D |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 208 | 159.679 | 33,213 | D |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 102 | 158.1954 | 16,136 | D |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 11 Apr 2024 | Sale | 2,811 | 147.7432 | 415,306 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 11 Apr 2024 | Sale | 5,008 | 146.088 | 731,609 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 11 Apr 2024 | Sale | 4,265 | 146.816 | 626,170 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Apr 2024 | Sale | 60 | 150.85 | 9,051 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Apr 2024 | Sale | 2,641 | 149.7931 | 395,604 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Apr 2024 | Sale | 12,501 | 149.1539 | 1,864,573 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Apr 2024 | Sale | 11,514 | 148.3962 | 1,708,634 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 09 Apr 2024 | Sale | 7,924 | 154.2084 | 1,221,947 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 09 Apr 2024 | Sale | 2,734 | 153.472 | 419,592 | I |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 09 Apr 2024 | Sale | 542 | 152.2839 | 82,538 | I |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 100 | 184.17 | 18,417 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 182.625 | 36,525 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 181.365 | 36,273 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 307 | 180.2574 | 55,339 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 993 | 179.3276 | 178,072 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 1,801 | 178.0995 | 320,757 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 5,994 | 177.1106 | 1,061,601 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 2,737 | 176.3476 | 482,663 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 200 | 169.05 | 33,810 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 733 | 166.4439 | 122,003 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 2,602 | 165.4876 | 430,599 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 12,069 | 164.4877 | 1,985,202 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 15,466 | 163.7793 | 2,533,011 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 6,598 | 162.7378 | 1,073,744 | D |
04 Mar 2024 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 29 Feb 2024 | Sale | 397 | 167.08 | 66,331 | D |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 1,008,660 | 180.5 | 182,063,130 | I |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 91,340 | 180.5 | 16,486,870 | I |
02 Aug 2023 17:10 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 31 Jul 2023 | Sale | 791 | 216.2567 | 171,059 | D |
06 Jul 2023 17:02 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 03 Jul 2023 | Sale | 472 | 179.5495 | 84,747 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 5 | 183.15 | 916 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 1,103 | 181.9144 | 200,652 | D |
27 Jun 2023 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 23 Jun 2023 | Sale | 840 | 182.85 | 153,594 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 478 | 182.6515 | 87,307 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 100 | 180.74 | 18,074 | D |
27 Jun 2023 17:20 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 26 Jun 2023 | Sale | 1,495 | 182.365 | 272,636 | D |
20 Jun 2023 18:53 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 20 Jun 2023 | Sale | 1,325 | 192.4192 | 254,955 | D |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 14 Jun 2023 | Sale | 273,728 | 207.7171 | 56,857,986 | I |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 13 Jun 2023 | Sale | 313,400 | 128.4335 | 40,251,059 | I |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 13 Jun 2023 | Sale | 611,000 | 211.4522 | 129,197,294 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 12 Jun 2023 | Sale | 968,812 | 213.9125 | 207,240,997 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 12 Jun 2023 | Sale | 281,400 | 130.8322 | 36,816,181 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 09 Jun 2023 | Sale | 328,952 | 217.0183 | 71,388,604 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 09 Jun 2023 | Sale | 213,700 | 130.3523 | 27,856,287 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 08 Jun 2023 | Sale | 1,163,825 | 218.1443 | 253,881,790 | I |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 116 | 226.1511 | 26,234 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 111 | 225.2721 | 25,005 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)